Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents
about
Structural determinants for the inhibitory ligands of orotidine-5′-monophosphate decarboxylaseNovel Interactions of Fluorinated Nucleotide Derivatives Targeting Orotidine 5′-Monophosphate DecarboxylaseThe Leishmania donovani UMP Synthase Is Essential for Promastigote Viability and Has an Unusual Tetrameric Structure That Exhibits Substrate-controlled OligomerizationAtomic Resolution Structure of the Orotidine 5'-Monophosphate Decarboxylase Product Complex Combined with Surface Plasmon Resonance Analysis: IMPLICATIONS FOR THE CATALYTIC MECHANISMFragment-Based Screening for Inhibitors of PDE4A Using Enthalpy Arrays and X-ray CrystallographyThe Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking InvestigationsSubtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of DNA polymerase III in Streptococcus species.Network-based assessment of the selectivity of metabolic drug targets in Plasmodium falciparum with respect to human liver metabolismCatalysis by orotidine 5'-monophosphate decarboxylase: effect of 5-fluoro and 4'-substituents on the decarboxylation of two-part substrates.Design of inhibitors of ODCase.Identification of Nucleoside Analogs as Inducers of Neuronal Differentiation in a Human Reporter Cell Line and Adult Stem Cells.
P2860
Q27661430-136DC7E8-E7B0-4D5D-99AE-2EAE675A8E78Q27667295-8FABC1D1-83E1-40CD-8A50-7FBBA1C18917Q27667488-9A0986E5-D04A-4F13-9110-FA1A0246974AQ27676270-972660F8-FA56-44EA-900A-D40B44A60326Q27676592-436A5673-851D-4C76-8117-D2B75D152EE0Q28066944-72F6DEC0-11E4-4B89-A333-AE6DDE4B3C80Q34194875-7ACD99F6-3B8B-4ACD-BE1A-A9F4394354BEQ34399911-C26AA6F3-D39D-4190-8E72-79695C0A47BDQ36566302-09B77B47-EA94-45D4-8D59-46FCD8BDF57FQ38182137-04C436B1-E436-40D1-931D-5F775E64E946Q38936117-648FB52B-26DD-4D22-AB6D-4BF2D4FDE24C
P2860
Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Structure-activity relationshi ...... nhibitors as anticancer agents
@ast
Structure-activity relationshi ...... nhibitors as anticancer agents
@en
Structure-activity relationshi ...... nhibitors as anticancer agents
@nl
type
label
Structure-activity relationshi ...... nhibitors as anticancer agents
@ast
Structure-activity relationshi ...... nhibitors as anticancer agents
@en
Structure-activity relationshi ...... nhibitors as anticancer agents
@nl
prefLabel
Structure-activity relationshi ...... nhibitors as anticancer agents
@ast
Structure-activity relationshi ...... nhibitors as anticancer agents
@en
Structure-activity relationshi ...... nhibitors as anticancer agents
@nl
P2093
P356
P1476
Structure-activity relationshi ...... nhibitors as anticancer agents
@en
P2093
Angelica M Bello
Caren Furlonger
Christopher J Paige
Danijela Konforte
Ewa Poduch
Lakshmi P Kotra
Lianhu Wei
P304
P356
10.1021/JM801224T
P407
P577
2009-03-26T00:00:00Z